Cargando…
Raf-mediated cardiac hypertrophy in adult Drosophila
In response to stress and extracellular signals, the heart undergoes a process called cardiac hypertrophy during which cardiomyocytes increase in size. If untreated, cardiac hypertrophy can progress to overt heart failure that causes significant morbidity and mortality. The identification of molecul...
Autores principales: | Yu, Lin, Daniels, Joseph, Glaser, Alex E., Wolf, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Limited
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701216/ https://www.ncbi.nlm.nih.gov/pubmed/23580199 http://dx.doi.org/10.1242/dmm.011361 |
Ejemplares similares
-
Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo
por: Clerk, Angela, et al.
Publicado: (2022) -
Cellular interplay via cytokine hierarchy causes pathological cardiac hypertrophy in RAF1-mutant Noonan syndrome
por: Yin, Jiani C., et al.
Publicado: (2017) -
A new Drosophila model of cardiac hypertrophy
Publicado: (2013) -
Raf Activation Is Regulated by Tyrosine 510 Phosphorylation in Drosophila
por: Xia, Fan, et al.
Publicado: (2008) -
RAS-dependent RAF-MAPK hyperactivation by pathogenic RIT1 is a therapeutic target in Noonan syndrome–associated cardiac hypertrophy
por: Cuevas-Navarro, Antonio, et al.
Publicado: (2023)